Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Exondys 51
Marketing
NS Pharma Duchenne drug wins speedy FDA nod to challenge Sarepta
FDA handed NS Pharma’s Viltepso a speedy FDA nod based on the same dystrophin production data that supported two Sarepta drugs' approvals.
Angus Liu
Aug 13, 2020 11:34am
Sarepta's new DMD drug wins FDA nod in surprising reversal
Dec 13, 2019 10:03am
Sarepta's Exondys therapy not cost-effective for patients: ICER
May 23, 2019 12:06pm
CHMP endorses Lilly's CGRP Emgality, Spark's Luxturna and more
Sep 21, 2018 11:58am
Sarepta CEO Ingram nabs $57M in 2017 pay
May 7, 2018 12:36pm
Sarepta’s CEO pick draws praise, takeover talk from analysts
Jun 29, 2017 5:58am
